These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 30743136

  • 1. Hypercapnic BOLD MRI compared to H215O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease.
    Hauser TK, Seeger A, Bender B, Klose U, Thurow J, Ernemann U, Tatagiba M, Meyer PT, Khan N, Roder C.
    Neuroimage Clin; 2019; 22():101713. PubMed ID: 30743136
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal Reproducibility of CO2-Triggered BOLD MRI for the Hemodynamic Evaluation of Adult Patients with Moyamoya Angiopathy.
    Roder C, Klose U, Hurth H, Brendle C, Tatagiba M, Ernemann U, Khan N, Hauser TK.
    Cerebrovasc Dis; 2021; 50(3):332-338. PubMed ID: 33556937
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quantitative cerebral perfusion imaging in children and young adults with Moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PET.
    Goetti R, Warnock G, Kuhn FP, Guggenberger R, O'Gorman R, Buck A, Khan N, Scheer I.
    AJNR Am J Neuroradiol; 2014 May; 35(5):1022-8. PubMed ID: 24335546
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hemodynamic evaluation of patients with Moyamoya Angiopathy: comparison of resting-state fMRI to breath-hold fMRI and [15O]water PET.
    Zerweck L, Roder C, Hauser TK, Thurow J, Mengel A, Tatagiba M, Khan N, Meyer PT, Ernemann U, Klose U.
    Neuroradiology; 2022 Mar; 64(3):553-563. PubMed ID: 34570251
    [Abstract] [Full Text] [Related]

  • 8. Neuropsychological impairment in adults with moyamoya angiopathy: preoperative assessment and correlation to MRI and H215O PET.
    Roder C, Haas P, Fudali M, Milian M, Ernemann U, Meyer PT, Tatagiba M, Khan N.
    Neurosurg Rev; 2020 Dec; 43(6):1615-1622. PubMed ID: 31728848
    [Abstract] [Full Text] [Related]

  • 9. Quality of life impairment in adult Moyamoya patients-preoperative neuropsychological assessment and correlation to MRI and H215O PET findings.
    Haas P, Fudali M, Wang SS, Hurth H, Hauser TK, Ernemann U, Tatagiba M, Khan N, Roder C.
    Neurosurg Rev; 2022 Apr; 45(2):1533-1541. PubMed ID: 34671887
    [Abstract] [Full Text] [Related]

  • 10. Staging Hemodynamic Failure With Blood Oxygen-Level-Dependent Functional Magnetic Resonance Imaging Cerebrovascular Reactivity: A Comparison Versus Gold Standard (15O-)H2O-Positron Emission Tomography.
    Fierstra J, van Niftrik C, Warnock G, Wegener S, Piccirelli M, Pangalu A, Esposito G, Valavanis A, Buck A, Luft A, Bozinov O, Regli L.
    Stroke; 2018 Mar; 49(3):621-629. PubMed ID: 29371433
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Simultaneous phase-contrast MRI and PET for noninvasive quantification of cerebral blood flow and reactivity in healthy subjects and patients with cerebrovascular disease.
    Ishii Y, Thamm T, Guo J, Khalighi MM, Wardak M, Holley D, Gandhi H, Park JH, Shen B, Steinberg GK, Chin FT, Zaharchuk G, Fan AP.
    J Magn Reson Imaging; 2020 Jan; 51(1):183-194. PubMed ID: 31044459
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic Failure Staging With Blood Oxygenation Level-Dependent Cerebrovascular Reactivity and Acetazolamide-Challenged (15O-)H2O-Positron Emission Tomography Across Individual Cerebrovascular Territories.
    Sebök M, van der Wouden F, Mader C, Pangalu A, Treyer V, Fisher JA, Mikulis DJ, Hüllner M, Regli L, Fierstra J, van Niftrik CHB.
    J Am Heart Assoc; 2023 Dec 19; 12(24):e029491. PubMed ID: 38084716
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cerebrovascular Reactivity Mapping Using Resting-State BOLD Functional MRI in Healthy Adults and Patients with Moyamoya Disease.
    Liu P, Liu G, Pinho MC, Lin Z, Thomas BP, Rundle M, Park DC, Huang J, Welch BG, Lu H.
    Radiology; 2021 May 19; 299(2):419-425. PubMed ID: 33687287
    [Abstract] [Full Text] [Related]

  • 16. Noninvasive Evaluation of CBF and Perfusion Delay of Moyamoya Disease Using Arterial Spin-Labeling MRI with Multiple Postlabeling Delays: Comparison with 15O-Gas PET and DSC-MRI.
    Hara S, Tanaka Y, Ueda Y, Hayashi S, Inaji M, Ishiwata K, Ishii K, Maehara T, Nariai T.
    AJNR Am J Neuroradiol; 2017 Apr 19; 38(4):696-702. PubMed ID: 28209582
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.